An injectable monoclonal antibody that targets the insulin-like growth factor I receptor improved proptosis in more than half of people with chronic thyroid eye disease, according to topline results ...
Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease May 5, 2026 8:00 ...
By Siddhi Mahatole May 5 (Reuters) - Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the ...
A second phase 3 trial of Viridian Therapeutics’ anti-IGF-1R antibody has hit its primary endpoint as the company prepares to ...
UniverSoul Circus is back in Atlanta for the first time since 2024, setting up its Big Top at the former Turner Field Grey ...
By Siddhi Mahatole May 5 (Reuters) - Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the main goal of a late-stage trial in chronic patients. The drug, elegrobart, ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today ...
UFC heavyweight champion Tom Aspinall has been sidelined for the past seven months unable to spar after suffering injuries to ...
Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...
All concerts begin at 5 p.m., and All Manor of Things, Historic Hopewell Foundation's gift ship, will be open. Audience ...
Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the main goal of a late-stage trial in chronic patients, sending its ​shares up nearly 50% before the bell. The drug ...
Iran executed three men on Sunday in connection with anti-government protests earlier this year. Mehdi Rasouli, Mohammad Reza Miri and Ebrahim Dolatabadi were all hanged in Mashhad. According to Iran ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results